PharmaCyte Biotech Cash from Financing (TTM) Analysis

PharmaCyte Biotech Inc (PMCB)

2.16 -0.02 (-0.76%) USD | NASDAQ | May 10, 16:00

2.16 0.00 (0.00%) After-Hours: 19:40

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2004. Upgrade now.

Date	Value
January 31, 2024	-4.318M
October 31, 2023	-1.057M
July 31, 2023	-5.191M
April 30, 2023	-13.56M
January 31, 2023	-9.304M
October 31, 2022	-5.526M
July 31, 2022	85.22M
April 30, 2022	87.31M
January 31, 2022	87.41M
October 31, 2021	87.37M
July 31, 2021	2.817M
April 30, 2021	4.637M
January 31, 2021	5.978M
October 31, 2020	6.466M
July 31, 2020	3.963M
April 30, 2020	2.726M
January 31, 2020	1.816M
October 31, 2019	1.831M
July 31, 2019	1.53M
April 30, 2019	2.342M
January 31, 2019	2.79M
October 31, 2018	2.325M
July 31, 2018	2.325M
April 30, 2018	2.681M
January 31, 2018	3.552M

Date	Value
October 31, 2017	5.390M
July 31, 2017	5.308M
April 30, 2017	4.882M
January 31, 2017	3.357M
October 31, 2016	3.082M
July 31, 2016	3.620M
April 30, 2016	3.568M
January 31, 2016	6.123M
October 31, 2015	5.429M
July 31, 2015	4.848M
April 30, 2015	3.642M
January 31, 2015	5.509M
October 31, 2014	5.358M
July 31, 2014	6.863M
April 30, 2014	8.531M
January 31, 2014	4.307M
October 31, 2013	3.837M
July 31, 2013	2.666M
April 30, 2013	1.221M
January 31, 2013	0.9672M
October 31, 2012	0.8996M
July 31, 2012	0.9138M
April 30, 2012	1.090M
January 31, 2012	1.065M
October 31, 2011	0.9565M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-13.56M

Minimum

Apr 2023

87.41M

Maximum

Jan 2022

17.90M

Average

2.726M

Median

Apr 2020

Cash from Financing (TTM) Benchmarks